Abstract
The dystonias are a group of serious movement disorders characterized by involuntary muscle spasms of different parts of the body. We recently proposed that hypofunction of dopamine D2 receptor-mediated inhibition of the indirect output pathway of the basal ganglia can result in dystonia. In this review, we discuss the results of a variety of genetic and biochemical studies in light of this hypothesis. Several forms of early-onset dystonia show distinct autosomal dominant, recessive, or X-linked genetic transmission patterns. Late onset forms of dystonia, though not showing clear Mendelian transmission patterns, also appear to be highly familial. Recently, several genetic-linkage locations have been identified for early-onset dystonia and for two of these loci, mutations decreasing dopamine synthesis have been demonstrated. Biochemical studies of monkeys and man also demonstrate that several types of dystonia occur in a dopamine-deficiency state. Similarly, mice strains developed to be deficient in several dopamine-pathway components have motor abnormalities consistent with dystonia. Hypofunction of the dopamine D2 receptormediated inhibition of the indirect output pathway of the putamen may be a common feature of many of these heritable and secondary dystonic syndromes.
Similar content being viewed by others
References
Accili D., Fishburn S., Drago J., Steiner H., Lachowicz J. E., Park B. H., Gauda E. B., Lee E. J., Cool M. H., Sibley D. R., Gerfen C. R., Wetsphal H., and Fuchs S. (1995) A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.Proc. Natl. Acad. Sci. USA 93, 1945–1949.
Albin R. L., Young A. B., and Penny J. B. (1989) The functional anatomy of basal ganglia disorders.Trends Neurosci. 12, 366–375.
Alexander G. and Crutcher M. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing.Trends Neurosci. 13, 266–271.
Ashizawa T., Patten B., and Jankovic J. (1980) Meige's syndrome.South. Med. J. 73, 863–866.
Baik J. H., Picetti R., Saiardi A., Thiriet G., Dierich A., Depaulis A., Le Meur M., and Borrelli E. (1995) Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors.Nature 377, 424–428.
Ballard P. A., Tetrud J. W., and Langston J. W. (1985) Permanent human parkinsonism due to 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases.Neurology 35, 949–956.
Bankiewicz K., Oldfield E., Chiueh C., Doppman J., Jacobowitz D., and Kopin I. (1986) Hemiparkinsonism in monkeys after unilateral internal carotid artery infusion of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).Life Sci. 39, 7–16.
Beales M., Lorden J. F., Walz E., and Oltmans G. A. (1990) Quantitative autoradiography reveals selective changes in cerebellar GABA receptors of the rat mutant dystonic.J. Neurosci. 10, 1874–1885.
Bhatia K. and Marsden C. D. (1994) The behavioural and motor consequences of focal lesions of the basal ganglia in man.Brain 117, 859–876.
Brashear A., Farlow M. R., Butler I. J., Kasarskis E. J., and Dobyns W. B. (1996) Variable phenotype of rapid-onset dystonia-parkinsonism.Mov. Disord. 11, 151–156.
Bressman S. G., de Leon D., Kramer P. L., Ozelius L. J., Brin M. F., Greene P. E., Fahn S., Breakefield X. O., and Risch N. J. (1994) Dystonia in Ashkenazi Jews: clinical characterization of a founder mutation.Ann. Neurol. 36, 771–777.
Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-1-4-phenyl-1,2,3,6-tetrahydropyridine.Proc. Natl. Acad. Sci. USA 80, 4546–4550.
Ceballos-Baumann A. O., Passingham R. E., Warner T., Playford E. D., Marsden C. D., and Brooks D. J. (1995) Overactive prefrontal and underactive motor cortical areas in idiopathic dystonia.Ann. Neurol. 37, 363–372.
Civelli O., Bunzow J. R., and Grandy D. K. (1993) Molecular diversity of the dopamine receptors.Ann. Rev. Pharmacol. Toxicol. 33, 281–307.
DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin.Trends Neurosci. 13, 281–285.
Drago J., Gerfen C. R., Lachowicz J. E., Steiner H., Hollon T. R., Love P. E., Ooi G. T., Grinberg A., Lee E. J., Huang S. P. (1994) Altered striatal function in a mutant mouse lacking D1A dopamine receptors.Proc. Natl. Acad. Sci. USA 91, 12,564–12,568.
Garver D., Davis J., Dekirmenjian H., et al. (1976) Dystonic reactions following neuroleptics: Time course and proposed mechanisms.Psychopharmacologia 47, 199–201.
Gasser T., Bove C. M., Ozelius L. J., Hallett M., Charness M. E., Hochberg F. H., and Breakefield X. O. (1996) Haplotype analysis at the DYT1 locus in Ashkenazi Jewish patients with occupational hand dystonia.Mov. Disord. 11, 163–166.
Gerfen C. R. (1992) The neostriatal mosaic: multiple levels of compartmental organization.Trends Neurosci. 15, 133–139.
Gerfen C. R., Engber T. M., Mahan L. C., Susel Z., Chase T. N., Monsma F. J. Jr., and Sibley D. R. (1990) D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.Science 250, 1429–1432.
Gerfen C. R., McGintry J. F., and Young W. S. (1991) Dopamine differentially regulates dynorphin, substance P and enkephalin expression in striatal neurons:In situ hybridization histochemical analysis.J. Neurosci. 11, 1016–1031.
Giros B., Jaber M., Jones S. R., Wightman R. M., and Caron M. D. (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.Nature 379, 606–612.
Guttman M., Fibiger H. C., Jakubovic A., and Calne D. G. (1990) Intracarotid 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine administration: biochemical and behavioral observations in a primate model of hemiparkinsonism.J. Neurochem. 54, 1329–1334.
Haberhausen G., Schmitt I., Kohler A., Peters U., Rider S., Chelly J., Terwilliger J. D., Monaco A. P., and Muller U. (1995) Assignment of the dystoniaparkinsonism syndrome locus, DYT3, to a small region within a 1.8-Mb YAC contig of Xq13.1.Am. J. Hum. Genet. 57, 644–650.
Hornykiewicz O., Kish S., Becker L., Farley I., and Shannak K. (1986) Brain neurotransmitters in dystonia musculorum deformans.N. Engl. J. Med. 315, 347–353.
Jinnah H. A., Wojcik B. E., Hunt M., Narang N., Lee K. Y., Goldstein M., Wamsley J. K., Langlais P. J., and Friedmann T. (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease.J. Neurosci. 14, 1164–1175.
Joyce J. N., Marshall J. F., Bankiewicz K. S., and Kopin I. J. (1986) Hemiparkinsonism in a monkey after unilateral internal carotid artery infusion of 1-methy-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is associated with regional ipsilateral changes in striatal dopamine D2 receptor density.Brain Res. 382, 360–364.
Keefe K. A. and Gerfen C. R. (1995) D1–D2 dopamine receptor synergy in striatum: Effects of intrastriatal infusions of dopamine agonists and antagonists on immediate early gene expression.Neuroscience 66, 903–913.
Knappskog P. M., Flatmark T., Mallet J., Lhdecke B., and Bartholom J. K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381K) in the tyrosine hydroxylase gene.Hum. Mol. Genet. 4, 1209–1212.
Kolbe H., Clow A., Jenner P., and Marsden C. D. (1981) Neuroleptic-induced acute dystonic reactions may be due to enhanced dopamine release on to supersensitive postsynaptic receptors.Neurology 31, 434–439.
Lang A. E. (1995) Hemiatrophy, juvenile-onset exertional alternating leg paresis, hypotonia and hemidystonia and adult-onset hemiparkinsonism: the spectrum of hemiparkinsonism-hemiatrophy syndrome.Mov. Disord. 10, 489–495.
Liu I. S. C., Seeman P., Sanyal S., Ulpian C., Rodgersjohnson P. E. B., Serjeant G. R. and Van Tol H. H. M. (1996) Dopamine D4 receptor variant in Africans, D4 (valine 194glycine), is insensitive to dopamine and clozapine—Report of a homozygous individual.Am. J. Med. Genet. 6, 277–282.
Lobos E. A. and Todd R. D. (1997) Cladistic analysis of disease association with tyrosine hydroxylase: application to manic-depressive disease and alcoholism.Am. J. Med. Genet. (Neuropsychiatric Genetics) 74, 289–295.
Lorden J. F., McKeon T. W., Baker H. J., Cox N., and Walkley, S. U. (1984) Characterization of the rat mutant dystonic (dt): a new animal model of dystonia musculorum deformans.J. Neurosci. 4, 1925–1932.
Lorden J. F., Oltmans G. A., Stratton S., and Mays L. E. (1988) Neuropharmacological correlates of the motor syndrome of the genetically dystonic (dt) rat.Adv. Neurol. 50, pp. 277–297.
Löscher W., Annies R., and Richter A. (1994) Marked regional disturbances in brain metabolism of monoaminergic neurotransmitters in the genetically dystonic hamster.Brain Res. 658, 199–208.
Löscher W., Fisher J. E., Jr., Schmidt D., Fredow G., Hńack D., and Iturrian W. B. (1989) The sz mutant hamster: a genetic model of epilepsy or of paroxysmal dystonia?.Mov. Disord. 4, 219–232.
Ludecke B., Knappskog P. M., Clayton P. T., Surtees R. A. H., Clelland J. D., Heales S. J. R., Brand M. P., Bartholome K., and Flatmark T. (1996) Recessively inherited L-dopa-responsive parkinsonism in infancy caused by a point mutation (L205P) in the tyrosine hydroxylase gene.Hum. Mol. Genet. 5, 1023–1028.
Micheli S., Fernández-Pardal M., Quesada P., Brannan T., and Obeso J. A. (1994) Variable onset of adult inherited focal dystonia: a problem for genetic studies.Mov. Disord. 9, 64–68.
Mink J. W. (1996) The basal ganglia: focused selection and inhibition of competing motor programs.Prog. Neurobiol. 50, 3810–425.
Mink J. W. and Thach W. T. (1993) Basal ganglia intrinsic circuits and their role in behavior.Curr. Opin. Neurobiol. 3, 950–957.
Mitchell I., Luguin R., Boyce S., Clarke C., Robertson R., Sambrook M., and Crossman A. (1990) Neural mechanisms of dystonia: evidence from a 2-deoxyglucose uptake study in a primate model of dopamine agonist-induced dystoniaMov. Disord. 5, 49–54.
Nagatsu T. and Ichinose H. (1996) GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.Neurochem. Res. 21, 245–250.
Nobrega J. N., Richter A., Tozman N., Jiwa D., and Lscher W. (1996) Quantitative autoradiography reveals regionally selective changes in dopamine D1 and D2 receptor binding in the genetically dystonic hamster.Neuroscience 71, 927–936.
Nöthen N. M., Cichon S., Hemmer S., Hebebrand J., Ramschmidt H., Lehmkuhl G., Poustka F., Schmidt M., Catalano M., and Fimmers R. (1994) Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity.Hum. Mol. Genet. 3, 2207–2212.
O'Hara C., Uhland-Smith A., O'Malley K. L., and Todd R. D. (1996) Inhibition of dopamine synthesis by dopamine D2 and D3 but not D4 receptors.J. Pharm. Exp. Ther. 277, 186–192.
Ozelius L. J., Kramer P. L., de Leon D., Risch N., Bressman S. B., Schyback D. E., Brin M. F., Kwiatkowski D. J., Burke R. E., Gusella J. F., Fahn S., and Breakefield X. O. (1992) Strong allelic association between the torsion dystonia gene (DYTI) and loci on chromosome 9q34 in Ashkenazi Jews.Am. J. Hum. Genet. 50, 619–628.
Ozelius L., Kramer P. L., Moskowitz C. B., Kwiatkowski D. J., Brin M. F., Bressman S. B., Schuback D. E., Falk C. T., Risch N., de Leon D., Burke R. E., Haines J., Gusella J. F., Fahn S., and Breakefield X. O. (1989) Human gene for torsion dystonia located on chromosome 9q32-q34.Neuron 2, 1427–1434.
Ozelius L. J., Hewett J. W., Page C. G., et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein.Nature Genet. 17, 40–48.
Palombo E., Porrino L. J., Bankiewicz K. S., Crane A. M., Sokoloff L., and Kopin I. J. (1990) Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP.J. Neurosci. 10, 860–869.
Perlmutter J. S., Stambuk M. K., Markham J., Black K. J., McGee-Minnich, Jankovic J., and Moerlein S. M. (1997) Decreased [18F]spiperone binding in putamen in idiopathic focal dystonia.J. Neurosci. 17, 843–850.
Perlmutter J. S., Tempel L. W., and Lich L. (1993) A new animal model of dystonia.Soc. Neurosci. Abstr 19, 1052.
Perlmutter J. S., Tempel L. W., Black K. J., Parkinson D., and Todd R. D. (1997) MPTP induced dystonia and parkinsonism: clues to the pathophysiology of dystonia.Neurology (in press).
Playford E., Fletcher N., Sawle G., Marsden C. D., and Brooks D. (1993) Striatal [18F]dopa uptake in familial idiopathic dystonia.Brain 116, 1191–1199.
Rupniak N., Jenner P., and Marsden C. D. (1986) Acute dystonia induced by neuroleptic drugs.Psychopharmacology 88, 403–419.
Stojanović M., Cvetković D., and Kostić V. S. (1995) A genetic study of idiopathic focal dystonias.J. Neurol. 242, 508–511.
Strange P. G. (1993) Dopamine receptors in the basal ganglia: Relevance to Parkinson's disease.Mov. Disord. 8, 263–270.
Surmeier D. J., Reiner A., Levine M. S., and Ariano M. A. (1993) Are neostriatal dopamine receptors co-localized?Trends Neusoci. 16, 299–305.
Tang L., Todd R. D., and O'Malley K. L. (1994) Dopamine D2 and D3 receptors inhibit dopamine release.J. Pharmacol. Exp. Ther. 270, 475–479.
Tempel L. W. and Perlmutter J. S. (1990) Abnormal vibration-induced cerebral blood flow responses in idiopathic dystonia.Brain 113, 691–707.
Tempel L. W. and Perlmutter J. S. (1993) Abnormal cortical responses in patients with writer's cramp.Neurology 43, 2252–2257.
Thomas S. A. and Palmiter R. D. (1997) Thermoregulatory and metabolic phenotypes of mice lacking noradrenaline and adrenaline.Nature 387, 94–97.
Todd R. D. Carl J., Harmon S., O'Malley K. L., and Perlmutter J. S. (1966) Dynamic changes in striatal dopamine D2 and D3 receptor protein and mRNA in response to 1-methyl-4-phenyl-1,2,3,6, tetrahydropyridine (MPTP) denervation in baboons.J. Neurosci. 16, 7776–7782.
Waddy H., Fletcher N., Harding A., and Marsden C. (1991) A genetic study of idiopathic focal dystonias.Ann. Neurol. 29, 320–324.
Williams A. C. (1995) Dopamine, dystonia, and the deficient co-factor.Lancet 345, 1130.
Zhou Q. Y. and Palmiter R. D. (1995) Dopamine-deficient mice are severely hypoactive, adipsic and aphagic.Cell 83, 1197–1209.
Zhou Q. Y., Quaife C. J., and Palmiter R. D. (1995) Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development.Nature 374, 640–643.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Todd, R.D., Perlmutter, J.S. Mutational and biochemical analysis of dopamine in dystonia. Mol Neurobiol 16, 135–147 (1998). https://doi.org/10.1007/BF02740641
Issue Date:
DOI: https://doi.org/10.1007/BF02740641